These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation. Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407 [TBL] [Abstract][Full Text] [Related]
12. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909 [TBL] [Abstract][Full Text] [Related]
13. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279 [TBL] [Abstract][Full Text] [Related]
14. Development of spin-labeled probes for adenosine receptors. Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453 [TBL] [Abstract][Full Text] [Related]
15. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777 [TBL] [Abstract][Full Text] [Related]
16. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. Yan L; Müller CE J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists. Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists. Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912 [TBL] [Abstract][Full Text] [Related]